(Q49154119)

English

Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study.

scientific article published on 26 June 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

0 references

Christopher Griffiths

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

author name string

E Daudén

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

J-P Ortonne

3

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

K Kragballe

4

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

C T Molta

5

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

D Robertson

6

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

R Pedersen

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

J Estojak

8

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

R Boggs

9

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

publication date

26 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

23

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

12

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

1374-1382

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

Epidemiology of psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Measuring disability and quality of life in established rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Impact of stroke on health-related quality of life in the noninstitutionalized population in the United States.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Health-related quality of life is related to COPD disease severity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Psoriasis causes as much disability as other major medical diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

A randomized trial of etanercept as monotherapy for psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

10 years experience of the Dermatology Life Quality Index (DLQI).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Translating the science of quality of life into practice: What do dermatology life quality index scores mean?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Current severe psoriasis and the rule of tens.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Health-related quality of life measured with EQ-5D in patients treated for depression in primary care

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Comparison of the EQ-5D and SF-12 in an adult US sample

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2009.03321.X

21 January 2018

Identifiers

10.1111/J.1468-3083.2009.03321.X

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/19563497

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49154119&oldid=2117950733"